Stay updated on Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Locations now lists Cincinnati, Ohio as a study site under the Locations section. The Ohio Locations subsection was removed and the HHS Vulnerability Disclosure link was deleted.
    Difference
    0.2%
    Check dated 2025-12-23T20:34:52.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    The Publications section description was updated to note that articles are automatically filled from PubMed, and the corresponding revision label changed from v3.2.0 to v3.3.2.
    Difference
    0.1%
    Check dated 2025-11-25T10:59:49.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The notice about government funding and NIH/CC operating status has been removed. The page now presents the study details (title, conditions, interventions, eligibility) without that status message. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:57:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The screenshots show only minor UI/formatting updates with no changes to core study details such as the study design, inclusion criteria, primary outcomes, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-03T21:03:09.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Major update: operating-status notice and new version v3.2.0; old v3.1.0 reference removed.
    Difference
    5%
    Check dated 2025-10-06T06:57:11.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    The page now shows the revision as v3.1.0 instead of v3.0.2. If there are no other visible content changes, this indicates a new release/version update.
    Difference
    0.1%
    Check dated 2025-09-29T03:31:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Chemoradiation in Laryngeal Cancer Clinical Trial page.